1.
Chest
; 111(6): 1778-81, 1997 Jun.
Article
in English
| MEDLINE
| ID: mdl-9187213
ABSTRACT
Intravenous haloperidol is recommended as the drug of choice to treat delirium in ICU patients. Movement disorders and other adverse events commonly occur with oral haloperidol use but are rarely seen with IV haloperidol use, and withdrawal symptoms have not been reported with short-term ICU use. We describe self-limited dyskinesia during withdrawal of high-dose continuous IV haloperidol therapy in five ICU patients.
Subject(s)
Critical Care , Delirium/complications , Dyskinesia, Drug-Induced/etiology , Haloperidol/adverse effects , Substance Withdrawal Syndrome/diagnosis , Adult , Delirium/drug therapy , Dyskinesia, Drug-Induced/diagnosis , Female , Haloperidol/administration & dosage , Humans , Infusions, Intravenous , Male , Middle Aged , Time Factors
2.
Neurology
; 42(11): 2220-2, 1992 Nov.
Article
in English
| MEDLINE
| ID: mdl-1436544
